← Back to Sector Map

MET

Financials · Life & Health Insurance

METLIFE INC

$70.97

+1.18%

AI Research

MetLife Q1 Dividend $0.5675 Declared → Stock at $69.16, Analysts See 33% Upside at $92 PT

MixedBuyPT $92.47

MetLife declared its Q1 2026 dividend of $0.5675 per share while the stock trades around $69.16, with analysts projecting approximately 33% upside to the consensus average price target of $92.47, suggesting the stock is significantly undervalued on a fundamental basis. The insurance giant's diversified business across group benefits, retirement, and international markets provides stable earnings. Risks include potential credit losses in commercial real estate and corporate bond portfolios, lower-than-expected investment yields, and competitive pressure in the group benefits market.

Key Stats

Market Cap$45.6B
P/E (TTM)14.7
Fwd P/E6.3
Beta0.74
Div Yield328.00%
Prev Close$70.14

52-Week Range

$65.21$70.97$85.00